Choo Heng Tong
Chief Executive Officer @ SG Growth Capital
Choo Heng Tong is a Series D investor at SG Growth Capital focused on Health Care and Biotechnology. Heng Tong holds dual appointments as Executive Vice President (Investments) at EDBI and Bio*One Capital, its dedicated biomedical sciences investment subsidiary. He is responsible for EDBI’s strategic growth capital for local companies as well as venture investments in biomedical sciences, and also oversee EDBI’s operations in the United States. Hehas over 15 years of experience in investments and industry development; including M&As, strategic planning, business development, and international growth into new markets, involving both multi-nationals and start-up organizations. He was previously with Singapore Economic Development Board where he worked with various industries such as biotechnology, pharmaceutical, and engineering companies to grow their business and operations in Asia. Currently, Heng Tong serves on the board of Maccine Pte Ltd, S*Bio Pte Ltd, QT Vascular Pte Ltd, Jurong Aromatics Corporation Pte Ltd and SPRING’s Growth Enterprise Fund Pte Ltd.
- Total investments:
- 1
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Choo Heng Tong invests in
Stages Choo Heng Tong invests in
Countries Choo Heng Tong invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TriReme Medical
|
TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations. | $17M / Series D |
Co-Investors
About SG Growth Capital
SG Growth Capital is an investment firm
SG Growth Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Choo Heng Tong
Chief Executive Officer
|
|||
Paul Ng
Chief Corporate Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Choo Heng Tong invest in?
Choo Heng Tong invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Choo Heng Tong?
Public channels for Choo Heng Tong include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
